Current issues of ACP Journal Club are published in Annals of Internal Medicine


Correction

Correction - Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria

PDF

ACP J Club. 2002 Jul-Aug;137:A17. doi:10.7326/ACPJC-2002-137-1-A17a

Related Content in the Archives
• Corrected Abstract or Commentary: Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria



In the Patients section of the abstract “Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria” (1), the two ≥ symbols should be ≤ symbols.


Reference

1. Rabbat CG. Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria [Abstract]. ACP J Club. 2002 May-Jun;136:82.